Company Filing History:
Years Active: 2016
Title: Michael Preigh: Innovator in Pharmaceutical Science
Introduction
Michael Preigh is a notable inventor based in Boulder, Colorado. He has made significant contributions to the field of pharmaceutical science, particularly in the development of innovative drug formulations. His work focuses on enhancing the efficacy of treatments through advanced chemical compositions.
Latest Patents
Michael Preigh holds a patent for "Solid dispersions of a ERB2 (HER2) inhibitor." This patent describes a solid dispersion of N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine and processes for preparing the solid dispersion. Additionally, it includes a pharmaceutical composition comprising this solid dispersion and its various uses.
Career Highlights
Michael Preigh is currently employed at Array Biopharma Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in developing new therapies that target specific cancer pathways, contributing to advancements in personalized medicine.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including David Fry and Christopher M. Lindemann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field.
Conclusion
Michael Preigh's contributions to pharmaceutical science through his innovative patents and collaborations highlight his role as a key figure in the industry. His work continues to pave the way for advancements in cancer treatment and drug formulation.